DRKS00032782进行中（未招募）不适用
Long-term follow-up of patients with adenocarcinoma of the Esophagus treated with perioperative chemotherapy (FLOT Protocol) or neoadjuvant chemoradiation (CROSS Protocol) (ESOFU Observational Study) - ESOFU
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 145
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 —（—）
- 性别
- All
入选标准
- •Participation in the ESOPEC trial
- •Ability to understand character and individual consequences of the
- •Written informed consent has been obtained
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
Solid tumorRollover Study (CA239-0071)Solid TumorsjRCT2061260044170
招募中
2 期
A Clinical Trial for Patients with Advanced Cancers2024-515020-36-00Corbus Pharmaceuticals Inc.108
招募中
2 期
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib StudiesNCT07415031Mirati Therapeutics Inc.170
招募中
1 期
A study in people with advanced cancer to test how well different doses of BI 3819026 are tolerated when taken alone and together with ezabenlimabunresectable advanced or metastatic solid cancer2025-522953-21-00Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.12
已完成
1 期
A study in people with advanced cancer to test whether the amount of BI 907828 in the blood is influenced by taking an OATP inhibitor or a CYP3 inhibitor2024-514532-24-00Boehringer Ingelheim International GmbH33